{"id":"79af1772-cc80-4ac7-abe1-60a8ea799ed8","name":"Neptune Medical","slug":"neptune-medical","description":"Menlo Park, CA-based GI robotics developer. Founder/CEO Alex Tilson. $97M Series D ([August](/companies/august-robotics) 2024). Investors: Sonder Capital, Olympus Corporation. Product: Pathfinder sleeve (wraps around endoscope, stiffens to prevent loops). Subsidiaries: Jupiter Endovascular (spun out with $21M, Endoportal Control for pulmonary embolism, led by Carl St. Bernard), Triton Medical Robotics (flexible endoluminal surgical device). Focus: GI robotics.","status":"private","founded":0,"hq":"Menlo Park, CA","hqLat":37.4519671,"hqLng":-122.177992,"hqGeocodedAt":"2026-08-05T14:40:48.373Z","hqAddress":null,"hqPrecision":null,"website":"neptunemedical.co.uk","fundingTotal":"291000000","type":"hardware","roles":[],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.massdevice.com/neptune-medical-raises-97m-gi-robotics/","title":"Neptune Medical raises $97M for GI robotics","sourceName":"MassDevice","dateAccessed":"2026-07-22"},{"url":"https://www.fiercebiotech.com/medtech/gi-robotics-developer-neptune-medical-raises-97m-launches-jupiter-endovascular","title":"Neptune Medical raises $97M, launches Jupiter","sourceName":"Fierce Biotech","dateAccessed":"2026-07-22"}],"keyFacts":[{"label":"Series D","value":"$97M (August 2024, Sonder Capital + Olympus)"},{"label":"Founder/CEO","value":"Alex Tilson"},{"label":"Product","value":"Pathfinder — endoscope stiffening sleeve for GI procedures"},{"label":"Subsidiaries","value":"Jupiter Endovascular (spun out, $21M, pulmonary embolism), Triton Medical Robotics"},{"label":"HQ","value":"Menlo Park, CA"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-22T21:32:37.672Z","updatedAt":"2026-08-21T17:43:59.040Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/neptune-medical","url":"https://registry.deploy.report/companies/neptune-medical","name":"Neptune Medical","description":"Menlo Park, CA-based GI robotics developer. Founder/CEO Alex Tilson. $97M Series D ([August](/companies/august-robotics) 2024). Investors: Sonder Capital, Olympus Corporation. Product: Pathfinder sleeve (wraps around endoscope, stiffens to prevent loops). Subsidiaries: Jupiter Endovascular (spun out with $21M, Endoportal Control for pulmonary embolism, led by Carl St. Bernard), Triton Medical Robotics (flexible endoluminal surgical device). Focus: GI robotics.","identifier":"79af1772-cc80-4ac7-abe1-60a8ea799ed8","address":"Menlo Park, CA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":2,"primary_source_types":[]}}}